Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 5
2011 9
2012 5
2013 4
2014 11
2015 14
2016 5
2017 13
2018 4
2019 7
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
The impact of response kinetics for multiple myeloma in the era of novel agents.
Yan Y, Mao X, Liu J, Fan H, Du C, Li Z, Yi S, Xu Y, Lv R, Liu W, Deng S, Sui W, Wang Q, Zou D, Wang J, Cheng T, Zhan F, Tai YT, Yuan C, Du X, Qiu L, Anderson KC, An G. Yan Y, et al. Among authors: yi s. Blood Adv. 2019 Oct 8;3(19):2895-2904. doi: 10.1182/bloodadvances.2019000432. Blood Adv. 2019. PMID: 31594763 Free PMC article.
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Alatrash G, Perakis AA, Kerros C, Peters HL, Sukhumalchandra P, Zhang M, Jakher H, Zope M, Patenia R, Sergeeva A, Yi S, Young KH, Philips AV, Cernosek AM, Garber HR, Qiao N, Weng J, St John LS, Lu S, Clise-Dwyer K, Mittendorf EA, Ma Q, Molldrem JJ. Alatrash G, et al. Among authors: yi s. Clin Cancer Res. 2018 Jul 15;24(14):3386-3396. doi: 10.1158/1078-0432.CCR-17-2626. Epub 2018 Apr 16. Clin Cancer Res. 2018. PMID: 29661776 Free article.
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
García-Barchino MJ, Sarasquete ME, Panizo C, Morscio J, Martinez A, Alcoceba M, Fresquet V, Gonzalez-Farre B, Paiva B, Young KH, Robles EF, Roa S, Celay J, Larrayoz M, Rossi D, Gaidano G, Montes-Moreno S, Piris MA, Balanzategui A, Jimenez C, Rodriguez I, Calasanz MJ, Larrayoz MJ, Segura V, Garcia-Muñoz R, Rabasa MP, Yi S, Li J, Zhang M, Xu-Monette ZY, Puig-Moron N, Orfao A, Böttcher S, Hernandez-Rivas JM, Miguel JS, Prosper F, Tousseyn T, Sagaert X, Gonzalez M, Martinez-Climent JA. García-Barchino MJ, et al. Among authors: yi s. J Pathol. 2018 May;245(1):61-73. doi: 10.1002/path.5060. Epub 2018 Mar 30. J Pathol. 2018. PMID: 29464716
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.
Qin XQ, An G, Li ZJ, Liu LT, Xu Y, Yang LH, Ma YP, Deng SH, Sui WW, Qin Y, Feng XY, Zang MR, Yang WJ, Zhang YR, Yi SH, Wang TY, Lv R, Zou DH, Zhao YZ, Qiu LG. Qin XQ, et al. Blood Adv. 2019 Mar 12;3(5):751-760. doi: 10.1182/bloodadvances.2018019851. Blood Adv. 2019. PMID: 30833275 Free PMC article.
miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K, Feng X, Wang Y, Liu Y, Tian L, Zuo W, Yi S, Wei X, Song Y, Qiu L. Zhou K, et al. Among authors: yi s. Exp Hematol. 2018 Feb;58:27-34.e1. doi: 10.1016/j.exphem.2017.10.005. Epub 2017 Nov 20. Exp Hematol. 2018. PMID: 29158064 Free article. Review.
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.
Chen R, Herrera AF, Hou J, Chen L, Wu J, Guo Y, Synold TW, Ngo VN, Puverel S, Mei M, Popplewell L, Yi S, Song JY, Tao S, Wu X, Chan WC, Forman SJ, Kwak LW, Rosen ST, Newman EM. Chen R, et al. Among authors: yi s. Clin Cancer Res. 2020 Mar 1;26(5):1034-1044. doi: 10.1158/1078-0432.CCR-19-1768. Epub 2019 Dec 6. Clin Cancer Res. 2020. PMID: 31811017
[Progress in the pathogenesis of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia].
Yi S, Qiu L. Yi S, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):568-70. doi: 10.3760/cma.j.issn.0253-2727.2014.06.024. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985190 Review. Chinese. No abstract available.
[Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma].
Yan Y, Yi S, Qiu L. Yan Y, et al. Among authors: yi s. Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):348-52. doi: 10.3760/cma.j.issn.0253-2727.2016.04.022. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27094004 Free PMC article. Chinese. No abstract available.
[Clinical Analysis of B-CLPD with Cytopemia as the Predominant Characteristic].
Lu R, Li ZJ, An G, Yi SH, Liu W, Wang TY, Deng SH, Sui WW, Zou DH, Qiu LG. Lu R, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Jun;27(3):839-843. doi: 10.19746/j.cnki.issn.1009-2137.2019.03.032. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 31204941 Chinese.
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
Xu Y, Deng S, Mao X, An G, Li Z, Wang Y, Fulciniti M, Ho M, Lin J, Sui W, Liu W, Zou D, Yi S, Huang W, Liu H, Lv R, Li J, Wang T, Du C, Munshi NC, Qiu L. Xu Y, et al. Among authors: yi s. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):422-430. doi: 10.1016/j.clml.2018.03.006. Epub 2018 Mar 15. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29625927 Free PMC article.
77 results
Jump to page
Feedback